UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial

A multi-institutional phase II trial was conducted to evaluate the efficacy and toxicity of combination chemotherapy consisting of gemcitabine and UFT, which is composed of tegafur and uracil, for non-small-cell lung cancer (NSCLC) patients. Patients with advanced NSCLC received an oral administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichinose, Y, Seto, T, Semba, H, Itoh, K, Inoue, Y, Tanaka, F, Araki, J, Tamanoi, M, Yamamoto, H, Iwamoto, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361641/
https://www.ncbi.nlm.nih.gov/pubmed/16175186
http://dx.doi.org/10.1038/sj.bjc.6602781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361641/
https://www.ncbi.nlm.nih.gov/pubmed/16175186
http://dx.doi.org/10.1038/sj.bjc.6602781

Ejemplares similares